Literature DB >> 538221

Plasma volume contraction: a significant factor in both pregnancy-associated hypertension (pre-eclampsia) and chronic hypertension in pregnancy.

E D Gallery, S N Hunyor, A Z Györy.   

Abstract

The role of plasma volume in hypertension in pregnancy (pre-eclampsia) was investigated. Significant volume expansion from non-pregnant levels (16.5 +/- 1.60 ml/cm height) was present throughout pregnancy in 189 normal women, reaching 23.1 +/- 1.21 ml/cm at 33-36 weeks amenorrhoea. In another 40 initially normotensive pregnant women who developed hypertension, similar early volume expansion was followed by significant volume contraction in the third trimester, before evaluation of blood pressure in 29 (20.6 +/- 1.26 ml/cm), after it in 11 (18.6 +/- 1.27 ml/cm). Equivalent volume contraction was present in another 44 women studied only after hypertension developed in the third trimester. Oedema had no value as a clinical sign. In another 30 women with chronic hypertension, blood pressure was inversely related to plasma volume (r = 0.822) and to fetal growth (r = -0.710), which was directly related to plasma volume (r = 0.701). Plasma volume depletion plays a significant role in hypertension in pregnancy.

Entities:  

Mesh:

Year:  1979        PMID: 538221

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  28 in total

Review 1.  Report of the Canadian Hypertension Society Consensus Conference: 2. Nonpharmacologic management and prevention of hypertensive disorders in pregnancy.

Authors:  J M Moutquin; P R Garner; R F Burrows; E Rey; M E Helewa; I R Lange; S W Rabkin
Journal:  CMAJ       Date:  1997-10-01       Impact factor: 8.262

Review 2.  Endogenous digitalis: pathophysiologic roles and therapeutic applications.

Authors:  Alexei Y Bagrov; Joseph I Shapiro
Journal:  Nat Clin Pract Nephrol       Date:  2008-06-10

Review 3.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

4.  Long-term presence of angiotensin II type 1 receptor autoantibody reduces aldosterone production by triggering Ca2+ overload in H295R cells.

Authors:  Jinghui Lei; Suli Zhang; Pengli Wang; Yang Liao; Jingwei Bian; Xiaochen Yin; Ye Wu; Lina Bai; Feng Wang; Xiaoli Yang; Huirong Liu
Journal:  Immunol Res       Date:  2018-02       Impact factor: 2.829

5.  Renin-Angiotensin-Aldosterone Profiles in Pregnant Women With Chronic Hypertension.

Authors:  Line Malha; Cristina P Sison; Geraldine Helseth; Jean E Sealey; Phyllis August
Journal:  Hypertension       Date:  2018-06-25       Impact factor: 10.190

6.  Treatment of hypertension in pregnancy with beta-adrenoceptor antagonists.

Authors:  D Dubois; J Petitcolas; B Temperville; A Klepper; P Catherine
Journal:  Br J Clin Pharmacol       Date:  1982       Impact factor: 4.335

Review 7.  Anaesthesia and pre-eclampsia.

Authors:  D H Morison
Journal:  Can J Anaesth       Date:  1987-07       Impact factor: 5.063

Review 8.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

9.  The relationship of plasma volume, sympathetic tone, and proinflammatory cytokines in young healthy nonpregnant women.

Authors:  Ira M Bernstein; Dana Damron; Adrienne L Schonberg; Reem M Sallam; Robert Shapiro
Journal:  Reprod Sci       Date:  2009-06-16       Impact factor: 3.060

Review 10.  Uric acid as a pathogenic factor in preeclampsia.

Authors:  S A Bainbridge; J M Roberts
Journal:  Placenta       Date:  2008-02-21       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.